Seres Therapeutics Inc Stock, NASDAQ:MCRB
200 Sidney Street, 4th floor, Cambridge, Massachusetts 02139
United States of America
Number of Employees: 155
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.